XML 49 R39.htm IDEA: XBRL DOCUMENT v3.23.1
EQUITY METHOD INVESTMENTS (Details Narrative)
3 Months Ended
Mar. 31, 2023
USD ($)
Mar. 31, 2023
CAD ($)
Mar. 31, 2023
EUR (€)
Mar. 31, 2022
USD ($)
Dec. 31, 2022
USD ($)
Sep. 30, 2019
Gain on extinguishment of debt $ 1,908,513     $ 1,004,124    
Cosmo Farmacy LP [Member]            
Initial share capital | €     € 150,000      
Initial share capital increased | €     500,000      
Pharmacy license value | €     € 350,000      
Maturity period of license 30 years 30 years 30 years      
Ownership equity           70.00%
Cash contributed to limited partner | €     € 150,000      
Equity ownership remaining           30.00%
Marathon Global Inc [Member] | Distribution and Equity Acquisition Agreement [Member]            
Upfront cash received   $ 2,000,000        
Fair value of settlement account $ 1,554,590          
Gain on extinguishment of debt $ 1,554,590          
Agreement term 5 years 5 years 5 years      
Cash received upon gross sales   $ 2,750,000        
Marathon Global Inc [Member] | Distribution and Equity Acquisition Agreement [Member] | Gross Sales One [Member]            
Cash received upon gross sales   2,750,000        
Gross sales   13,000,000        
Marathon Global Inc [Member] | Distribution and Equity Acquisition Agreement [Member] | Gross Sales [Member]            
Gross sales   $ 6,500,000        
Share Exchange Agreement [Member] | ICC [Member]            
Investement $ 163,080       $ 160,470